Literature DB >> 16911312

Scaffold-free, engineered porcine cartilage construct for cartilage defect repair--in vitro and in vivo study.

Kwideok Park1, Jinsong Huang, Frederick Azar, Ri L Jin, Byoung-Hyun Min, Dong K Han, Karen Hasty.   

Abstract

This study introduces an implantable scaffold-free (SF) cartilage tissue construct that is composed of chondrocytes and their self-produced extracellular matrix (ECM). Chondrocytes were isolated from the articular cartilages from knees of domestic pigs (2-week old) and monolayer-cultured for 3-4 days in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum and 50 microg/mL of ascorbic acid. Briefly treated with 0.25% trypsin-ethylenediaminetetraacetic acid (EDTA), an intact chondrocytes/ECM membrane, as a cell sheet was released from the plate bottom and subsequently centrifuged into a pellet-type construct. Each was grown in vitro for up to 5 weeks and subjected to various assays at different time points (1, 7, 14, 21, and 35 days). For in vivo implantation, full-thickness defects (n = 4) were manually created on the femoro-patellar groove of the left porcine knee and 1-week-cultured SF construct was implanted as an allograft for a month. One defect (#1) was an empty control and the remaining three received different recipes; construct only (#2) or 0.25% trypsin/EDTA-treated first and then construct and collagen gel (#3) or construct and collagen gel (#4). While the total cell numbers significantly increased by 2 weeks and then remained stable, cell viability stayed in the mid-70% range through the entire culture period. Biochemical assay found continuous glycosaminoglycan (GAG) accumulation. Histology exhibited that cell distribution was even in the construct and GAG intensity became stronger and uniform with time. Real-time reverse transcription polymerase chain reaction (RT-PCR) results showed that phenotypic stability peaked at 2 weeks, which was arable to that of freshly isolated chondrocytes. Upon analysis of the retrieved implants, some promising results were witnessed in the defects (#3) retaining not only their intact mass but also chondrocytic morphology with lacuna formation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16911312     DOI: 10.1111/j.1525-1594.2006.00267.x

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  10 in total

1.  The role of tissue engineering in articular cartilage repair and regeneration.

Authors:  Lijie Zhang; Jerry Hu; Kyriacos A Athanasiou
Journal:  Crit Rev Biomed Eng       Date:  2009

2.  The maturity of tissue-engineered cartilage in vitro affects the repairability for osteochondral defect.

Authors:  Cheng Zhe Jin; Jae-Ho Cho; Byung Hyune Choi; Li Ming Wang; Moon Suk Kim; So Ra Park; Jeong Ho Yoon; Jung Ho Yun; Hyun Ju Oh; Byoung-Hyun Min
Journal:  Tissue Eng Part A       Date:  2011-10-17       Impact factor: 3.845

3.  Effects of Cartilage Progenitor Cells, Bone Marrow Mesenchymal Stem Cells and Chondrocytes on Cartilage Repair as Seed Cells: An in vitro Study.

Authors:  Jiaxiang Gu; Bin Wang; Tianliang Wang; Naichen Zhang; Hongjun Liu; Jianchao Gui; Yiming Lu
Journal:  Drug Des Devel Ther       Date:  2022-04-28       Impact factor: 4.319

4.  In vitro construction of scaffold-free cylindrical cartilage using cell sheet-based tissue engineering.

Authors:  Gakuto Tani; Noriaki Usui; Masafumi Kamiyama; Takaharu Oue; Masahiro Fukuzawa
Journal:  Pediatr Surg Int       Date:  2009-11-27       Impact factor: 1.827

5.  Alteration of the fibrocartilaginous nature of scaffoldless constructs formed from leporine meniscus cells and chondrocytes through manipulation of culture and processing conditions.

Authors:  Daniel J Huey; Kyriacos A Athanasiou
Journal:  Cells Tissues Organs       Date:  2013-02-12       Impact factor: 2.481

6.  Intravenous administration of anti-vascular endothelial growth factor humanized monoclonal antibody bevacizumab improves articular cartilage repair.

Authors:  Toshihiro Nagai; Masato Sato; Toshiharu Kutsuna; Mami Kokubo; Goro Ebihara; Naoshi Ohta; Joji Mochida
Journal:  Arthritis Res Ther       Date:  2010-09-24       Impact factor: 5.156

7.  Scaffold-free approach produces neocartilage tissue of similar quality as the use of HyStem™ and Hydromatrix™ scaffolds.

Authors:  Janne H Ylärinne; Chengjuan Qu; Mikko J Lammi
Journal:  J Mater Sci Mater Med       Date:  2017-02-16       Impact factor: 3.896

8.  Methods for producing scaffold-free engineered cartilage sheets from auricular and articular chondrocyte cell sources and attachment to porous tantalum.

Authors:  G Adam Whitney; Hisashi Mera; Mark Weidenbecher; Amad Awadallah; Joseph M Mansour; James E Dennis
Journal:  Biores Open Access       Date:  2012-08

9.  A comparative study of aggrecan synthesis between natural articular chondrocytes and differentiated chondrocytes from adipose derived stem cells in 3D culture.

Authors:  Malek Masoud Ansar; Ebrahim Esfandiariy; Mohmmad Mardani; Batool Hashemibeni; Sayeed Hamid Zarkesh-Esfahani; Masoud Hatef; Azadeh Kabiri
Journal:  Adv Biomed Res       Date:  2012-07-06

Review 10.  Scaffold-free tissue engineering for injured joint surface restoration.

Authors:  Kazunori Shimomura; Wataru Ando; Hiromichi Fujie; David A Hart; Hideki Yoshikawa; Norimasa Nakamura
Journal:  J Exp Orthop       Date:  2018-01-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.